Back to Search Start Over

Plasma and Platelet Transfusion Strategies in Critically Ill Children With Malignancy, Acute Liver Failure and/or Liver Transplantation, or Sepsis: From the Transfusion and Anemia EXpertise Initiative–Control/Avoidance of Bleeding

Authors :
Lani, Lieberman
Oliver, Karam
Simon J, Stanworth
Susan M, Goobie
Gemma, Crighton
Ruchika, Goel
Jacques, Lacroix
Marianne E, Nellis
Robert I, Parker
Katherine, Steffen
Paul, Stricker
Stacey L, Valentine
Marie E, Steiner
Michelle, Demetres
Source :
Pediatr Crit Care Med
Publication Year :
2022
Publisher :
Ovid Technologies (Wolters Kluwer Health), 2022.

Abstract

To present the consensus statements with supporting literature for plasma and platelet transfusions in critically ill neonates and children with malignancy, acute liver disease and/or following liver transplantation, and sepsis and/or disseminated intravascular coagulation from the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding.Systematic review and consensus conference of international, multidisciplinary experts in platelet and plasma transfusion management of critically ill children.Not applicable.Critically ill neonates and children with malignancy, acute liver disease and/or following liver transplantation, and sepsis and/or disseminated intravascular coagulation.None.A panel of 13 experts developed evidence-based and, when evidence was insufficient, expert-based statements for plasma and platelet transfusions in critically ill neonates and children with malignancy, acute liver disease and/or following liver transplantation, and sepsis and/or disseminated intravascular coagulation. These statements were reviewed and ratified by the 29 Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding experts. A systematic review was conducted using MEDLINE, EMBASE, and Cochrane Library databases, from inception to December 2020. Consensus was obtained using the Research and Development/University of California, Los Angeles Appropriateness Method. Results were summarized using the Grading of Recommendations Assessment, Development, and Evaluation method. We developed 12 expert consensus statements.In the Transfusion and Anemia EXpertise Initiative-Control/Avoidance of Bleeding program, the current absence of evidence for use of plasma and/or platelet transfusion in critically ill children with malignancy, acute liver disease and/or following liver transplantation, and sepsis means that only expert consensus statements are possible for these areas of practice.

Details

ISSN :
15297535
Volume :
23
Database :
OpenAIRE
Journal :
Pediatric Critical Care Medicine
Accession number :
edsair.doi.dedup.....75412cb81c21f1cd78dfbdda5b77b05e
Full Text :
https://doi.org/10.1097/pcc.0000000000002857